Scientific Highlights

2. Juni 2022

NMB/Eckelman Young Investigator Award 2022

Chiara Favaretto, PhD student in the “Radionuclide Development” group at the Center for Radiopharmaceutical Sciences, received the NMB/Eckelman Young Investigator Award for the abstract entitled: “Production and radiochemical separation of terbium-155 from enriched gadolinium target material and its preliminary application in SPECT imaging”, presented at the International Symposium on Radiopharmaceutical Sciences (iSRS 2022).

10. Januar 2022

Millions in funding for brain and quantum research

Research Using Synchrotron Light Materials Research Biology Health Innovation Future Technologies Quantum Research

The European Research Council approves PSI projects for the development of a quantum computer and brain research worth about 5 million euros.

21. Dezember 2021
Cristina Müller and Nick van der Meulen

Terbium Triumph

Bench-to-bedside successes: Fruitful collaborations at PSI’s Center for Radiopharmaceutical Sciences make bringing Terbium-161 to the clinic a reality.

16. Dezember 2021
Ligand induced dimerization of GPCR

Biased signalling for better drugs

A dream drug would provide a targeted therapeutic effect without side effects. Biased signalling could make this a reality. Publishing in PNAS, PSI researchers present a platform for biased signalling-based drug discovery.

15. Dezember 2021

Fingerprint of Copper in Peptides Linked to Alzheimer's Disease

In an interdisciplinary project, researchers from the Laboratory of Nanoscale Biology in BIO  and the Laboratory for Condensed Matter in PSD have revealed the reaction between the nitrogen atoms of the amyloid-beta peptide and copper/zinc ions by using soft X-ray absorption spectroscopy.